← Back to screener

OPKO HEALTH, INC. OPK

Rank #1624 · Nasdaq · $1.3B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
45.4
P/E
-6.6
P/B
0.80
ROE
-12.1%
Op. Margin
-18.2%
Debt Ratio
53%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★☆☆
Average

P/E -6.6x, P/B 0.80x. Ranks in the top 50% of the universe.

Profitability ★☆☆☆☆
Weak

ROE -12.1%. Ranks in the top 80% of the universe.

Safety ★★★★☆
Good

Debt ratio 53%. Ranks in the top 25% of the universe.

Growth ★☆☆☆☆
Poor

Revenue decline of 14.0% year over year. Ranks in the top 87% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$-0.0B$-0.0B$0.0B–7985
2012–$-0.0B$-0.0B$0.0B–140
2013–$-0.0B$-0.0B$0.2B–48
2014–$-0.0B$-0.0B$0.9B–59
2015–$-0.1B$-0.1B$0.8B–51
2016–$-0.1B$-0.2B$0.9B–94
2017–$-0.1B$-0.0B$0.8B–81
2018$1.1B$-0.1B$-0.0B$2.0B-8.638
2019$1.0B$-0.3B$-0.3B$2.0B-28.632
2020$1.0B$-0.2B$-0.2B$1.8B-17.338
2021$0.9B$-0.3B$-0.3B$1.8B-30.445
2022$1.4B$0.1B$0.0B$1.6B4.044
2023$1.8B$0.0B$-0.0B$1.7B1.136
2024$1.0B$-0.2B$-0.3B$1.7B-22.537
2025$0.9B$-0.2B$-0.2B$1.6B-18.253

← See the full screener